Back
Sleep Number 10K Form
Sell
30
SNBR
Sleep Number
Last Price:
12.48
Seasonality Move:
8.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-03-02 | 10K | SNBR/Sleep Number Annual |
2020-10-23 | 10Q | SNBR/Sleep Number Quarterly |
2020-07-24 | 10Q | SNBR/Sleep Number Quarterly |
2020-05-01 | 10Q | SNBR/Sleep Number Quarterly |
2020-02-25 | 10K | SNBR/Sleep Number Annual |
2019-10-25 | 10Q | SNBR/Sleep Number Quarterly |
Receive SNBR News And Ratings
See the #1 stock for the next 7 days that we like better than SNBR
SNBR Financial Statistics
Sales & Book Value
Annual Sales: | $1.89B |
---|---|
Cash Flow: | $24.16M |
Price / Cash Flow: | 0 |
Annual Sales: | $-20.06 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -1.81000 |
---|---|
Net Income (TTM): | $-40.86M |
Gross Margin: | $1.09B |
Return on Equity: | 0% |
Return on Assets: | -4.47% |
Sleep Number Earnings Forecast
Key Sleep Number Financial Ratios
- The Gross Profit Margin over the past 27 years for SNBR is 57.67%.
- The Selling, General & Administrative Expenses for SNBR have been equal to 52.67% of Gross Profit Margin.
- The Research & Development expenses have been 2.96% of Revenue.
- The Interest Expense is -279.29% of Operating Income.
- The Net Earning history of SNBR is -0.81% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 16 years.
Sleep Number Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Specialty Retail |
Sector: | Consumer Discretionary |
Current Symbol: | SNBR |
CUSIP: | 83125X |
Website: | sleepnumber.com |
Debt
Debt-to-Equity Ratio: | -1.15 |
---|---|
Current Ratio: | 0.19 |
Quick Ratio: | 0.02 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 45.49 |
SNBR Technical Analysis vs Fundamental Analysis
Sell
30
Sleep Number (SNBR)
is a Sell
Is Sleep Number a Buy or a Sell?
-
Sleep Number stock is rated a Sell
The current Sleep Number [SNBR] share price is $12.49. The Score for SNBR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.